Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Neoplasms 1Lung Neoplasms 1Lung Diseases 1Hypertension, Pulmonary 1

Interventions

Carboplatin 10Paclitaxel 5Nivolumab 4Pemetrexed 3Cisplatin 3atezolizumab 2apatinib 2Surveys and Questionnaires 2One-Lung Ventilation 2Ipilimumab 2Blood Specimen Collection 2Bevacizumab 2zimberelimab 1toripalimab 1spartalizumab 1sitravatinib 1sintilimab 1sacituzumab govitecan 1pembrolizumab 1lorlatinib 1cemiplimab 1camrelizumab 1Vital Signs 1Vinorelbine 1Tyrosine Kinase Inhibitors 1Tomography, Emission-Computed, Single-Photon 1Temozolomide 1Telescopes 1Talc 1Saline Solution 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Lung Diseases × Natriuretic Peptide, Brain × Clear all
NCT00075179 2018-11-07

Natrecor in Pulmonary Hypertension

M.D. Anderson Cancer Center

Phase 4 Terminated
15 enrolled
Thoracic

Hypertension, Pulmonary, Lung Diseases, Lung Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡